Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human neutrophil elastase (HNE) is a serine protease enzyme found in neutrophils. It plays a crucial role in host defense by degrading proteins during inflammation and infection. However, its dysregulation is implicated in tissue damage and diseases like emphysema, cystic fibrosis, and congenital neutropenia. It is a target for drug discovery, with inhibitors like sivelestat under investigation for therapeutic use. Alpha-1 antitrypsin (A1AT) is the primary endogenous inhibitor.
Inhibition of neutrophil elastase activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Neutrophil Elastase (HNE).